ClinicalTrials.gov
ClinicalTrials.gov Menu

Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00083954
Recruitment Status : Completed
First Posted : June 7, 2004
Last Update Posted : January 4, 2013
Sponsor:
Information provided by:
AstraZeneca

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : August 2005